三黄鸡a干扰素的克隆、表达及抗病毒活性初步研究

采用PCR方法从三黄鸡血液基因组中扩增鸡α干扰素全基因,并克隆和测序.序列分析表明,基因全长为582 bp,亚克隆其成熟蛋白编码基因489 bp.将该片段与表达载体pET-28a连接克隆至大肠埃希菌DH5α菌株,经测序和酶切鉴定,选取正向插入、读码框正确的阳性克隆.构建重组质粒并转化BL21(DE3),经IPTG诱导,...     

重组酵母鸡α干扰素的诱导表达及其抗MDV、NDV能力

【目的】获得鸡α干扰素重组酵母菌诱导表达的最佳诱导时间和甲醇的体积分数,并测定诱导表达产物对鸡马立克氏病毒(MDV)和鸡新城疫病毒(NDV)的抑制能力。【方法】挑取2个鸡α干扰素重组酵母菌单菌落至BMGY培养基中培养,待菌液OD600为4左右时,分别转接至BMMY培养液诱导,1瓶每隔12 h补加1次体积分数0.5%甲醇,另1瓶每隔12 h补加1次体积分数1%甲醇,于24,48,72 h收集样品,备SDS-PAGE检测用。根据不同时间(24,48,72,96 h)诱导上清液表达量的差异,留用表达量最高时段的上清液,经初步纯化后,利用鸡胚成纤维细胞(CEF),分别测定重组酵母鸡α干扰素抑制MDV及NDV的能力。【结果】鸡α干扰素重组酵母菌在每隔12 h补加1次体积分数1%甲醇诱导48 h时,或每隔12 h补加1次体积分数0.5%甲醇诱导72 h时,重组酵母鸡α干扰素表达量均达到最高;且诱导上清液具有较好地抑制MDV、NDV的能力。【结论】获得了鸡α干扰素重组酵母菌小量发酵的最佳条件;获得的重组酵母鸡α干扰素对MDV和NDV有明显的抑制作用。     

Effects of HIF-1α silencing on proliferation of rat hepatoma cells

AIM：To study the effect of hypoxia-inducible factor 1α (HIF-1α) silencing on the proliferation of hepatoma cells under hypoxia. METHODS：Rat hepatoma cell line CBRH-7919 was used in this study. Hypoxia model was established by treating the cells with cobalt chloride (CoCl2). The expression of HIF-1α was silenced by small interfe-rence RNA. Real-time RT-PCR and Western blotting were used to detect the mRNA and/or protein expression of HIF-1α, vascular endothelial growth factor (VEGF), p21 and cyclin D1 in CBRH-7919 cells under hypoxia. The proliferation of CBRH-7919 cells was measured by the technique of 5-bromo-2’-deoxyuridine (BrdU) incorporation. RESULTS：The expression of HIF-1α and VEGF at mRNA and protein levels was significantly increased under hypoxia (P<0.05). Silencing of HIF-1α significantly inhibited the expression of HIF-1α, VEGF and cyclin D1 at mRNA and/or protein levels, while increased the protein expression of p21 (P<0.05). The BrdU-positive cells in HIF-1α siRNA transfection group were significantly less than those in control group. CONCLUSION：HIF-1α silencing significantly inhibits the proliferation of hepatoma cells under hypoxia.     

Effects of HIF-1α/SDF-1 signaling axis on hypoxia-induced migration and adhesion of progenitor cells

AIM: To observe the expression of hypoxia-inducible factor-1alpha (HIF-1α) and stromal cell-derived factor 1 (SDF-1) in pulmonary artery endothelial cells (PAECs) of SD rats and to investigate the role of HIF-1α/SDF-1 signaling axis on hypoxia-induced migration and adhesion of progenitor cells to PAECs. METHODS: Immunomagnetic beads were used to separate and purify the CD34⁺/CXCR4⁺ progenitor cells derived from the peripheral circulation of SD rats. The expression of HIF-1α and SDF-1 in PAECs exposed to hypoxia (1% O₂, 5% CO₂ and 94% N₂) was detected by immunofluorescence, Western blotting and ELISA. The migration index and adhesion rate were measured in the progenitor cells, which were subjected to the following different treatments: (1) normoxia (21% O₂); (2) hypoxia 12 h; (3) hypoxia 12 h +HIF-1α inhibitor (2ME2); (4) hypoxia 12 h+SDF-1 neutralizing antibody; (5) hypoxia 12 h+2ME2+SDF-1 neutralizing antibody.RESULTS: The expression of HIF-1α and SDF-1 in PAECs was effectively induced by the hypoxic exposure, and both of them reached the peak levels after 12 h of hypoxic treatment (P<0.01), while administration of 2ME2 decreased the hypoxia-induced SDF-1 expression (P<0.05). Treatment of the PAECs with 2ME2 or SDF-1 neutralizing antibody attenuated the migration index and adhesion rate of progenitor cells to the PAECs (P<0.05). CONCLUSION: There is a HIF-1α/SDF-1 signaling axis in hypoxia-exposed PAECs, which may play a crucial role in the migration and adhesion of progenitor cells to PAECs.     

犬α1干扰素在毕赤酵母中的分泌表达及其抗病毒活性研究

亚克隆犬α1干扰素(CaIFN-α1)成熟蛋白编码基因并克隆到表达载体pPICZα-A,构建转移重组载体pPICZα-A-CaIFN-α。pPICZα-A-CaIFN-α经SacⅠ酶切线性化后电转化导入毕赤酵母菌株X-33。转化子经PCR分析鉴定后利用甘油增菌和甲醇诱导,实现了CaIFN-α1在毕赤酵母系统中的分泌表达。SDS-PAGE检测结果表明表达产物相对分子质量约为2.7×104,比其推导结果(约1.9×104)大,推测可能是发生了糖基化。酵母分泌表达的CaIFN-α1具有较高的抗病毒活性,约为1.45×106U·mL-1,蛋白含量约为96mg·L-1,比活性为1.49×107U·mg-1。重组CaIFN-α1的生物学活性具有较强的种属特异性,在犬肾细胞(MDCK)上具有很高的抗病毒活性,在鸡胚成纤维细胞上活性较低,而在猫肾细胞(F81)和牛肾细胞(MDBK)上几乎没有抗病毒活性。进一步研究发现,重组犬α1干扰素对犬瘟热病毒和伪狂犬病毒在犬肾细胞中的增殖具有显著抑制作用。     

胸腺肽αl原核表达载体的构建及在大肠杆菌中的表达

构建胸腺肽αl（Thymosin αl，Tαl）基因原核表达载体，并在大肠杆菌BL21中进行表达，为大量获得胸腺肽αl打下基础。将人工合成的Tαl三串体基因插入到表达载体pET32a后，CaC12法转化大肠杆菌BL21，经氨苄青霉素筛选后用IPTG诱导表达，SDS-PAGE检测BL21中胸腺肽αl的表达。大肠杆菌中检测到与目的蛋白相对分子量(31kD)相符的条带。成功构建了Tαl原核表达载体，该蛋白能在大肠杆菌中表达。     

美洲大蠊对低免疫力小鼠免疫功能的影响

用环磷酰胺造低免疫力小鼠模型,再分别用低、中、高剂量的美洲大蠊粉给小鼠灌胃,研究虫粉对小鼠吞噬细胞的吞噬指数、血清溶血素含量、外周血CD4/CD8和免疫器官指数的影响,结果表明,高剂量虫粉组的血清溶血素含量和外周血CD4/CD8与模型对照组相比均有显著提高(P<0.05),中、高剂量虫粉组吞噬细胞的吞噬指数比模型对照组显著提高(P<0.05),说明美洲大蠊虫粉能提高低免疫力小鼠的免疫功能.     

串联的人胸腺素α1基因在番茄中的高效表达

 【目的】提高免疫活性多肽人胸腺素α1（Tα1）在番茄中的表达量。【方法】根据植物偏爱密码子对Tα1基因进行优化，并将其顺式串联成四联体，同时在单体基因间插入肠激酶剪切位点基因序列，以便表达的融合蛋白可以被肠激酶切割成单体。利用农杆菌介导法将单体Tα1基因和四联体Tα1基因分别转化进入番茄。【结果】两个基因转化番茄后分别得到卡那霉素抗性再生植株19株和10株，PCR和Southern杂交检测证明，部分番茄基因组中整合了外源基因。经过Western和ELISA分析，串联的Tα1基因已经在番茄果实中表达，表达量最高相当于20.2 μg Tα1?g-1果实鲜重，高于单体基因的表达量。【结论】基因串联的方式提高了Tα1基因在番茄中的表达量。     

Pharmacokinetics of detomidine and its metabolites following intravenous and intramuscular administration in horses

Reasons for performing study: Detomidine is commonly used i.v. for sedation and analgesia in horses, but the pharmacokinetics and metabolism of this drug have not been well described. Objectives: To describe the pharmacokinetics of detomidine and its metabolites, 3‐hydroxy‐detomidine (OH‐detomidine) and detomidine 3‐carboxylic acid (COOH‐detomidine), after i.v. and i.m. administration of a single dose to horses. Methods: Eight horses were used in a balanced crossover design study. In Phase 1, 4 horses received a single dose of i.v. detomidine, administered 30 μg/kg bwt and 4 a single dose i.m. 30 üg/kg bwt. In Phase 2, treatments were reversed. Plasma detomidine, OH‐detomidine and COOH‐detomidine were measured at predetermined time points using liquid chromatography‐mass spectrometry. Results: Following i.v. administration, detomidine was distributed rapidly and eliminated with a half‐life (t_1/2(el)) of approximately 30 min. Following i.m. administration, detomidine was distributed and eliminated with t_1/2(el) of approximately one hour. Following, i.v. administration, detomidine clearance had a mean, median and range of 12.41, 11.66 and 10.10–18.37 ml/min/kg bwt, respectively. Detomidine had a volume of distribution with the mean, median and range for i.v. administration of 470, 478 and 215–687 ml/kg bwt, respectively. OH‐detomidine was detected sooner than COOH‐detomidine; however, COOH‐detomidine had a much greater area under the curve. Conclusions and potential relevance: These pharmacokinetic parameters provide information necessary for determination of peak plasma concentrations and clearance of detomidine in mature horses. The results suggest that, when a longer duration of plasma concentration is warranted, the i.m. route should be considered.